At the end of this presentation, the participant will be able to:

• Explain the difference between a model-based dose calculation and TG-43 calculation
• Discuss wich anatomical sites will most benefit from higher dose calculation accuracy
• Discuss which new clinical approaches (ex: shielded applicators) model-based dose calculation will favor clinical implementation 

Evaluation